[Spastic torticollis].
Fifty-seven cases of spastic torticollis are reported, and its etiologic factors, including stressful situations, are analyzed. Plasma serotonin measurements have added new insight into pathogenetic mechanisms of the condition. The range of "reflex" spastic torticollis has been limited on the basis of biochemical and EMG findings. Fairly high incidence of attendant extrapyramidal symptoms and their polymorphism are pointed out, and, the need for a differential approach to the treatment of spastic torticollis being emphasized, a schedule of combined treatment, incorporating eglonyl and amitriptyline, is proposed for clonic-tonic torticollis.
Oboĭmov
E I
EI
Kolesova
O E
OE
D000639:Amitriptyline / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D009128:Muscle Spasticity / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D009334:Neck Muscles / Q000187:drug effects / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism*; D012702:Serotonin Antagonists / Q000008:administration & dosage; D013469:Sulpiride / Q000008:administration & dosage*; D014103:Torticollis / Q000188:drug therapy / Q000209:etiology* / Q000378:metabolism
D012702:Serotonin Antagonists; D000639:Amitriptyline; D012701:Serotonin; D013469:Sulpiride
Spasticheskaia krivosheia.